Arrail Group Limited
6639.HK
Hong Kong Stock Exchange1.83
HKD
+0.08
- -
Arrail Group Limited
6639.HK
(Hong Kong Stock Exchange)
Recent
price
1.83
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Arrail Group Limited (6639.HK) operates as a leading provider of premium private dental healthcare services in China, offering a comprehensive range of professional and customized dental treatments through its network of clinics and hospitals. Founded in 1999 and headquartered in Beijing, the company delivers general dentistry services, including oral examinations, treatment planning, preventive and cosmetic dentistry, endodontics, oral surgery, periodontal treatment, prosthodontics, pedodontics, and patient education; orthodontics treatments utilizing fixed and removable braces, headgear, aligners, and other appliances; and implantology solutions for complex cases involving artificial teeth implantation tailored to jawbone health and patient needs. It also engages in the wholesale of dental materials to third-party clinics and distributors, as well as denture manufacturing and hospital management activities. The company pursues a dual-brand strategy with Arrail Dental, its premium brand launched in 1999 targeting affluent consumers in Tier-1 and emerging Tier-1 cities such as Beijing, Shanghai, Shenzhen, Guangzhou, Hangzhou, Tianjin, and Xiamen; and Rytime Dental, its mid-market brand introduced in 2012 serving middle-class customers in Tier-1 and key Tier-2 cities across northern, eastern, southern, and western China. As of March 31, 2025, Arrail Group operates 118 facilities comprising 107 clinics (48 under Arrail Dental and 59 under Rytime Dental) and 11 hospitals under Rytime Dental, spanning 15 cities with 1,566 dental chairs and 999 full-time dentists, the majority holding advanced degrees and extensive experience. Its operations emphasize high medical standards, supported by over 3,111 employees focused on dental care in China's growing oral healthcare market. Recent developments include the opening of a new Rytime Dental hospital in Wuxi with 41 dental chairs during the year ended March 31, 2025, expanding total facilities and enhancing capacity in Tier-2 cities; growth in patient visits to 1,970,394, a 0.3% increase year-over-year, with repeat visit rates around 47.8%; and initiatives to bolster dentist numbers by 27 to 999 while advancing AI integration for imaging diagnosis, clinical documentation, and patient follow-up to improve efficiency. In June 2025, following the fiscal year-end, the company amended its loan agreement with Beier Holdings Limited, reducing principal from US$11 million to US$7.5 million and extending the term to 42 months, secured by additional share pledges representing about 9.1% of issued share capital. These efforts, alongside cost-control measures driving a 39.4% rise in operating profit to RMB36.2 million despite a 3.3% revenue dip to RMB1,688.4 million amid economic pressures, underscore Arrail Group's focus on operational optimization, network expansion, and sustainable growth in the dental sector.